within Pharmacolibrary.Drugs.ATC.M;

model M01AB15_1
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 5.833333333333333e-06,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.023166666666666665,
    Tlag           = 540,            
    Vdp             = 0.0081,
    k12             = 0.49,
    k21             = 0.49
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AB15_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for the short-term treatment of moderate to severe pain. It is typically administered for post-operative pain management and is not recommended for long-term use due to potential side effects, particularly on the gastrointestinal tract and kidneys. Ketorolac is approved and used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adults after oral administration.</p><h4>References</h4><ol><li><p>Mroszczak, EJ, et al., &amp; Massey, I (1990). Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. <i>Pharmacotherapy</i> 10(6 ( Pt 2)) 33S–39S. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2082311/\">https://pubmed.ncbi.nlm.nih.gov/2082311</a></p></li><li><p>Brocks, DR, &amp; Jamali, F (1992). Clinical pharmacokinetics of ketorolac tromethamine. <i>Clinical pharmacokinetics</i> 23(6) 415–427. DOI:<a href=\"https://doi.org/10.2165/00003088-199223060-00003\">10.2165/00003088-199223060-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1458761/\">https://pubmed.ncbi.nlm.nih.gov/1458761</a></p></li><li><p>Pasloske, K, et al., &amp; Conlon, P (1999). Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 22(5) 314–319. DOI:<a href=\"https://doi.org/10.1046/j.1365-2885.1999.00225.x\">10.1046/j.1365-2885.1999.00225.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10597535/\">https://pubmed.ncbi.nlm.nih.gov/10597535</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AB15_1;
